Amgen (AMGN)

Retained Earnings

-$22.28B

Quarterly · Period ending: · USD

AMGN logo

AMGN Retained Earnings

Latest reported-$22.28B
AMGN Quarterly Retained Earnings (-$20.90M → -$22.28B)
High-resolution chart · PNG

AMGN retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-22,275,000,000
-24,650,000,000
-25,107,000,000
-23,800,000,000
-25,708,000,000
-27,140,000,000
-27,590,000,000
-25,530,000,000
-27,124,000,000
-27,870,000,000
-26,549,000,000
-24,971,000,000
-25,540,000,000
-26,919,000,000
-28,622,000,000
-28,066,000,000
-28,252,000,000
-29,568,000,000
-24,600,000,000
-22,964,000,000
-22,762,000,000
-21,639,000,000
-21,408,000,000
-19,851,000,000
-20,168,000,000
-21,378,000,000
-21,330,000,000
-20,136,000,000
-20,054,000,000
-19,895,000,000
-17,977,000,000
-15,987,000,000
-15,266,000,000
-14,387,000,000
-5,072,000,000
1,774,000,000
1,378,000,000
233,000,000
-438,000,000
221,000,000
-356,000,000
-1,638,000,000
-2,086,000,000
-2,352,000,000
-2,912,000,000
-4,051,000,000
-4,624,000,000
-4,698,000,000
-5,476,000,000
-7,023,000,000
-7,634,000,000
-7,840,000,000
-8,854,000,000
-10,111,000,000
-10,423,000,000
-9,348,000,000
-9,380,000,000
-9,444,000,000
-8,919,000,000
-4,167,000,000
-1,945,000,000
-2,383,000,000
-3,508,000,000
-3,394,000,000
-4,266,000,000
-4,852,000,000
-4,322,000,000
-4,042,000,000
-5,423,000,000
-6,659,000,000
-5,258,000,000
-5,519,000,000
-6,653,000,000
-6,031,000,000
-7,160,000,000
-7,894,000,000
-8,093,000,000
-4,638,000,000
-5,203,000,000
-5,789,000,000
-6,385,000,000
-5,517,000,000
-3,132,000,000
-2,720,000,000
-2,918,000,000
-3,197,000,000
-2,376,000,000
-2,041,000,000
-884,400,000
-626,500,000
-667,000,000
-635,700,000
-924,600,000
-1,082,800,000
-1,126,000,000
-1,467,500,000
1,134,100,000
1,312,400,000
1,686,800,000
1,773,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.